RxDoctor Payments Data

Philip Moberg, MD

Rheumatology · Seattle, WANPI 1972745230

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 157 rheumatology providers in Washington.

See all rheumatology providers in Washington

Medicare billing

Part B allowed, 2024
$633,971
Medicare patients
323
Services billed
33,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KineretAnakinra13$434,763
Enbrel SureclickEtanercept27$268,387
EnbrelEtanercept25$232,569
SimponiGolimumab24$157,567
Cosentyx Sensoready PenSecukinumab13$111,867
OtezlaApremilast12$57,890
BenlystaBelimumab11$53,054
Hydroxychloroquine Sulfate175$7,871
MethotrexateMethotrexate Sodium267$6,501
Leflunomide83$5,552
Sulfasalazine94$2,939
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen128$2,891
Mycophenolate Mofetil20$2,665
Celecoxib35$1,428
Prednisone109$1,375

Paid to pharmacies, not to this prescriber.

Other rheumatology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →